Physician profile
Eric Tocci
NPI 1831136191
$593.75
in general payments reported to CMS, 2019-2025
15 companies · $52.24 in 2025
The $52.24 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2021: $83.64 · 2022: $178 · 2023: $36.31 · 2025: $52.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $149.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.26 | 2022 | |
| Daiichi Sankyo INC. | $67.64 | 2021-2025 | Enhertu |
| Novartis Pharmaceuticals Corporation | $53.65 | 2019-2022 | |
| Adc Therapeutics America, INC. | $25.67 | 2025 | |
| Novo Nordisk INC | $21.79 | 2019 | |
| Seagen INC. | $20.68 | 2023 | Tukysa |
| Eisai INC. | $19.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.46 | 2019 | |
| Amgen INC. | $17.66 | 2021 | |
| Merck Sharp & Dohme LLC | $17.33 | 2021 | |
| Leica Microsystems INC. | $16.86 | 2022 | |
| Hologic Sales and Service, LLC | $15.63 | 2023 | Horizon A, Affirm Prone Biopsy System, 3dimensions |
| Lilly USA, LLC | $14.79 | 2019 | |
| Puma Biotechnology, INC. | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Tocci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.